Literature DB >> 18771070

Laryngeal carcinoma in nonsmoking patients.

Yaniv Hamzany1, Tuvia Hadar, Raphael Feinmesser, Dan Guttman, Jacob Shvero.   

Abstract

OBJECTIVES: Smoking is a known risk factor for laryngeal carcinoma. We sought to describe the clinicopathologic characteristics and outcomes of nonsmoking patients with laryngeal carcinoma.
METHODS: Of 1,443 patients treated for laryngeal carcinoma between 1960 and 2006, 55 (3.8%) were nonsmokers: 40 (73%) had never smoked and 15 (27%) had stopped smoking 12 years or more before diagnosis. Patient characteristics and outcomes were reviewed.
RESULTS: The study group consisted of 87% men; the mean age at diagnosis was 67 years. All lesions but one were located in the glottis. The 5-year survival rate for the whole group was 85%. Most tumors were detected early. Of 38 patients (69%) with stage T1 disease, there was no significant difference in prognostic features between those who had never smoked and those who had smoked in the past.
CONCLUSIONS: Fewer than 5% of patients with laryngeal carcinoma were nonsmokers. Like smokers, this subgroup was characterized by a male predominance and an approximate age at diagnosis in the seventh decade. Unlike smokers, nonsmokers show a greater predilection for glottic rather than supraglottic disease. There was no difference in prognosis between smokers and nonsmokers, regardless of whether they had smoked in the past.

Entities:  

Mesh:

Year:  2008        PMID: 18771070     DOI: 10.1177/000348940811700802

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

1.  Molecular and immunologic analysis of laryngeal squamous cell carcinoma in smokers and non-smokers.

Authors:  Ian-James Malm; Lisa M Rooper; Justin A Bishop; Selmin Karatayli Ozgursoy; Alexander T Hillel; Lee M Akst; Simon R Best
Journal:  Am J Otolaryngol       Date:  2018-11-22       Impact factor: 1.808

2.  Analysis of failure following transoral laser surgery for early glottic cancer.

Authors:  Aviram Mizrachi; Naomi Rabinovics; Ohad Hilly; Jacob Shvero
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-05       Impact factor: 2.503

3.  Clinical Significance of miR-149 in the Survival of Patients with Laryngeal Squamous Cell Carcinoma.

Authors:  Yi Xu; Yun-Peng Lin; Dong Yang; Geng Zhang; Hui-Fang Zhou
Journal:  Biomed Res Int       Date:  2016-06-15       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.